4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-24-000015
Chief Business Officer gave up 1,735 shares (to pay taxes)
- Chief Business Officer acquired 27,300 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Boyle Scott N · Chief Business Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-13 | Shares withheld for taxes : show line 1 in the form | −1,735 | $6.53 | $11,330 | 25,030 | D |
| 2024-02-14 | Grant or award : show line 2 in the form | +27,300 | 52,330 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-14 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +122,800 | 122,800 | D |
Loading xslF345X05/wk-form4_1708034573.xml…